Showing 21 - 30 of 146
Persistent link: https://www.econbiz.de/10002195502
Persistent link: https://www.econbiz.de/10003231072
The recent surge in U.S. patenting and expansion of patentable subject matter has increased patent office backlogs and raised concerns that in some cases patents of insufficient quality or with inadequate search of prior art are being issued. At the same time patent litigation and its costs are...
Persistent link: https://www.econbiz.de/10013217190
We report the results of the first comparative study of the determinants and effects of patent oppositions in Europe and of re-examinations on corresponding patents issued in the United States. The analysis is based on a dataset consisting of matched EPO and US patents. Our analysis focuses on...
Persistent link: https://www.econbiz.de/10013218303
Numerous scholars have proposed many different explanations for why inventors and innovative companies patent. Few scholars, however, have conducted empirical studies seeking to confirm or deny these theories. Furthermore, there are only a handful of studies examining how entrepreneurs and...
Persistent link: https://www.econbiz.de/10014218807
In this paper, we examine the propriety of using patents as a proxy for firm innovative performance. We find that in the pharmaceutical industry during 1985-2001 they are not. Replicating the methodology in a study by Comanor and Scherer (1969) upon which many current studies base their use of...
Persistent link: https://www.econbiz.de/10014223139
Entrepreneurs often rely on intellectual property (IP) to earn a return on their innovations, and also compatibility standards, which allow them to supply specialized components for a shared technology platform. This paper compares the IP strategies of small entrepreneurs and large incumbents...
Persistent link: https://www.econbiz.de/10014046585
This article examines how closely nanotechnology resembles a general purpose technology (GPT). Using patented nanotechnology inventions during 1975-2006, we test for characteristics of GPTs identified in the prior literature, and find evidence that nanotechnology shows both “pervasive”...
Persistent link: https://www.econbiz.de/10014046863
We demonstrate the dual affects that regulatory rules and firms' complementary assets have on the timing of new product introductions in the pharmaceutical industry. We develop theory and evidence to explain how incumbent firms respond with new product introductions to a change in their...
Persistent link: https://www.econbiz.de/10014046996
This paper examines the role played by "continuations" (procedural revisions of patent applications) within software patenting and the implications that the use by patentees of continuations has for free and open-source software design. Our research analyzes data on continuations in software...
Persistent link: https://www.econbiz.de/10014067817